Read the full judgment text of HCCC 437/2015 on BabelCite. This High Court CFI judgment was delivered on 8 June 2017.
1. Different aspects of the evidence intended to be called by the prosecution were being challenged. I decided to first deal with the broad principles in relation to three areas, ie expertise of experts on Cytokine‑induced killer (CIK) cell infusion therapy, relevance of the Good Manufacturing Practice (GMP) Guidelines and whether this is a case of joint criminal enterprise. I gave my ruling on 8 June 2017 and I indicated at the time that I would give my reasons later. This I now do.
Cites 1 case